Beactica Therapeutics appoints Jarl Ulf Jungnelius M.D. to its Board of Directors as it advances towards clinical-stage activities ...Middle East

STOCKHOLM, June 19, 2023 /PRNewswire/ -- Beactica Therapeutics AB, the Swedish precision oncology company, today announced the appointment of Jarl Ulf Jungnelius M.D. to its Board of Directors. The appointment marks another step in Beactica's strategic plan to become a clinical-stage...

Hence then, the article about beactica therapeutics appoints jarl ulf jungnelius m d to its board of directors as it advances towards clinical stage activities was published today ( Monday 19/06/2023 - 10:41 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Beactica Therapeutics appoints Jarl Ulf Jungnelius M.D. to its Board of Directors as it advances towards clinical-stage activities )

Also on site :

• Rooster Runs Wild: Director Zach Braff Breaks Down Greg's Night Out In Episode 4 — And Working With John C. McGinley Across Two Shows
• China conducts patrols in disputed area of ​​the South China Sea
• Taylor Swift Narrowly Misses Ex-Boyfriend at Paul McCartney Concert